Your search matched 3 results
ICER Report on Pharmaceutical Insurance Coverage Puts Spotlight on Payers/PBMs | Blog
The Institute for Clinical and Economic Review (ICER) recently published its first Assessment of Barriers to Fair Access report examining coverage policies of 15 major commercial insurers
Prescription Drugs Covered under Medicare Part B Scrutinized as Part of ICER’s Annual Unsupported Price Increase (UPI) Report | Blog
As anticipated, the drug pricing watchdog group, the Institute for Clinical and Economic Review (ICER), published its fourth annual Unsupported Price Increase (UPI) Report on prescription drugs in the United States.
Drug Pricing Reform Legislation Resurrected by Democrats | Blog
Drug pricing legislation continues to forge ahead with a significant healthcare proposal back in play.
Already have a RSS feed reader?